It showed that a lot of the lean mass lost was in organs, like the liver, which lost fat mass (decreased fatty liver)
Research should strive to eliminate inequities in access to care and health outcomes among different populations
Given that cases are projected to increase worldwide over the coming decades especially in low- and middle-income countries there is an urgent need to develop and deploy effective treatments for the disease
Download Our Brochure on Metabolic Disease Models Explore Biocytogens Models for Obesity and Diabetes Drug Development Literature Reference: Prado, Carla M., et al
Weight loss may be slow initially, and you usually see the benefits a few weeks after being on these medications when your dose is increased
The SURMOUNT-4 trial for tirzepatide, which shares some receptor targets with retatrutide, showed that participants who stopped the drug regained about two-thirds of their lost weight within a year